FDA accepts BMS protein degrader for review; Disc rare disease drug rejected
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
Why are men more likely to develop multiple myeloma than women?
A study has unearthed potential reasons for sex differences that are observed in the clinical presentation of patients…
Multiple myeloma rates increasing twice as high in men than in women
Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and…
Largest Immune Cell Atlas of Multiple Myeloma Predicts Recurrence Risk
Credit: Md Saiful Islam Khan / iStock / Getty Images Plus Scientists across six leading U.S. institutions have…
Myeloma: How AI Is Redrawing the Map of Cancer Care
By: Monica Smith | December 19, 2025 | 6 min. read | Share Summary Sylvester Comprehensive Cancer Center’s innovative…